BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp® (NYSE: LH), a leading global life sciences company, today announced a new collaboration with HealthVerity, Inc., the ...

The yet-to-be-named new company will be publicly traded. Separating the laboratory testing work of LabCorp from the clinical trial services business, much of which came from acquisitions, will enable ...

Innovative collaboration advances the development of novel gene therapies for patients by providing coordinated services across Forge’s leading AAV manufacturing capabilities and Labcorp’s scientific ...

Laboratory Corporation of America Holdings or LabCorp LH continues to remain in the headlines with major back-to-back developments within the company’s business. Following last week’s announcement of ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that Thomas (Tom) Pike will join Labcorp as president and chief executive officer of its ...

BURLINGTON – Labcorp (NYSE: LH) will grow its international presence in Japan through expanding CB Trial Laboratory, the central laboratory co-managed by Labcorp Drug Development and BML, a leading ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

April 25 (Reuters) - Laboratory Corp of America Holdings (LH.N), opens new tab missed estimates for quarterly profit on Tuesday, as its drug development unit struggled against curbs on animal imports, ...

Laboratory Corp. of America Holdings LH-0.45%decrease; red down pointing triangle plans to spin off its unit focused on clinical drug trials, a move that will create a new stand-alone company in the ...

The positions in the table below reflect the Labcorp Drug Development's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to ...